Behemoth tablets is offered in 2 variants: 40mg S4, 25mg LGD 4033 and 25mg MK-677, totaling 90mg per tablet for 20 tablets or 1800mg in total; and 40mg S4, 25mg LGD 4033 and 25mg MK-677, totaling 90mg per tablet for 40 tablets or 3600mg in total.
A scientific study published in 2005 examined the effects of Andarine S-4 in the skeletal muscles, bones and pituitary glands of castrated male rats. A treatment protocol (3 and 10mg/kg S4- Andarine for 8 weeks) was commenced 12 weeks after castration. Andarine (doses 3 and 10 mg/kg) restored and soleus muscle mass and strength and levator ani muscle mass to that seen prior to castration or in intact animals.
This makes S4 an investigational selective androgen receptor modulator, for possible treatment of conditions related to muscle wasting, osteoporosis and benign prostatic hyperplasia (BPH). It has the ability to mimic many of the beneficial pharmacologic effects associated with testosterone.
|Molar Mass||128.3 g/mol-1|
Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis.
Recent studies investigated the effects of LGD 4033 on muscle tissue in ovariectomized rats. A daily dose of LGD was administered and calculated according to body weight of each individual rat at the onset of the study. Results and changes were noted as soon as week 2, the control group having weighed significantly less than rats undergoing LGD treatment. This difference remained until the end of the study, irrespective of LGD treatments. Additionally, the LGD treatments resulted in a higher number of capillaries in all muscles studied. Longer randomized trials and research could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.
|Molar Mass||338.253 g·mol−1|
A recent study set out to investigate the effects of MK-677 as a Ghrelin mimetic on body composition and clinical outcomes in healthy older adults. It was found that MK-677 enhanced fluctuating growth hormone secretion and markedly increased fat free mass over a 12-month period. More extensive research and randomized trials could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.
|Molar Mass||528.67 g·mol−1|
|IUPAC Name||2-amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H indole-3,4′-piperidine]-1′-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide|
By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority, if you are not 100% satisfied with the product you received, please contact us at firstname.lastname@example.org
We are not affiliated, associated, authorized, endorsed by, or in any way officially connected with SARMScentral.org, or any of its subsidiaries or its affiliates.